Marwah Vikas, Choudhary Robin, Bhati Gaurav, Malik Virender, Kumar V Pravin, Kumar Tentu Ajai, Pandey I M, Basnet Ashok
Professor & Head (Pulmonary, Critical Care & Sleep Medicine), Army Institute of Cardio Thoracic Sciences (AICTS), Pune, India.
Resident (Pulmonary, Critical Care & Sleep Medicine), Army Institute of Cardio Thoracic Sciences (AICTS), Pune, India.
Med J Armed Forces India. 2024 Dec;80(Suppl 1):S78-S83. doi: 10.1016/j.mjafi.2022.09.011. Epub 2022 Nov 24.
Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE). We aimed to analyze the risk factors, clinical presentations, evaluation and management strategies as well as outcomes of adult pulmonary thromboembolism cases at a tertiary care center.
In a retrospective observational study, all consecutive adult pulmonary thromboembolism cases admitted from January 2019 to September 2020 at our center were enrolled in this study.
Forty-eight patients were included in the present study. The commonest presenting features were dyspnea (93.8%) and cough (79.2%). The risk factors included hypertension 11 (23%), diabetes 6 (12%), recent trauma and recent surgery 3 (6%) each, and malignancy in 2 (4%). DVT was present in 12 (25%) cases while history of smoking was significant, 31 present in (64.6%). Tuberculosis was also found to be an important risk factor for PE in 8 (16.7%). The current COVID-19 pandemic has come up as an important risk factor for PTE which was also true in our case with 13 (27%) patients being cases of moderate to severe COVID-19 pneumonia. Electrocardiogram revealed sinus tachycardia (56.25%), precordial lead T-wave changes (6.3%), and S1Q3T3 pattern (16.67%). Diagnosis was confirmed by computed tomographic pulmonary angiography (CTPA) in 81% of cases. Treatment options included low molecular weight heparin (LMWH) in 91%, newer oral anticoagulants (NOACs) in 2% of the patients and thrombolysis was needed in 12.5% of patients. There was no in-hospital mortality; however one patient had major bleeding.
The clinical presentation of PE varied from dyspnea to cough, though the commonest feature of dyspnea remains unchanged compared to prior studies. CTPA has been modality of choice for diagnosis, however few patients with high probability for PTE were diagnosed clinically along with suggestive echocardiography and ECG findings. Thus, a high index of suspicion and timely therapeutic anticoagulation with various agents led to effective management and better outcome in the studied patients.
静脉血栓栓塞症(VTE)包括深静脉血栓形成(DVT)和肺栓塞(PE)。我们旨在分析一家三级医疗中心成年肺血栓栓塞症病例的危险因素、临床表现、评估和管理策略以及预后情况。
在一项回顾性观察研究中,纳入了2019年1月至2020年9月期间在我们中心连续收治的所有成年肺血栓栓塞症病例。
本研究共纳入48例患者。最常见的临床表现为呼吸困难(93.8%)和咳嗽(79.2%)。危险因素包括高血压11例(23%)、糖尿病6例(12%)、近期外伤和近期手术各3例(6%)、恶性肿瘤2例(4%)。12例(25%)患者存在DVT,吸烟史显著,有31例(64.6%)。还发现8例(16.7%)结核病是PE的重要危险因素。当前的新冠疫情已成为PTE的一个重要危险因素,在我们的病例中也是如此,13例(27%)患者为中重度新冠肺炎肺炎病例。心电图显示窦性心动过速(56.25%)、胸前导联T波改变(6.3%)和S1Q3T3图形(16.67%)。81%的病例通过计算机断层扫描肺血管造影(CTPA)确诊。治疗方案包括91%的患者使用低分子肝素(LMWH),2%的患者使用新型口服抗凝药(NOACs),12.5%的患者需要溶栓治疗。住院期间无死亡病例;然而,有1例患者发生大出血。
PE的临床表现从呼吸困难到咳嗽各不相同,尽管与先前研究相比,最常见的呼吸困难特征保持不变。CTPA一直是诊断的首选方式,然而,少数PTE高概率患者通过临床诊断以及超声心动图和心电图的提示性发现得以确诊。因此,高度的怀疑指数和及时使用各种药物进行治疗性抗凝导致了所研究患者的有效管理和更好的预后。